EGFRL858R-T790M-C797S NTCC? EGFR基因三突變細胞株

BioVector NTCC質粒載體菌株細胞蛋白抗體基因保藏中心

NTCC? EGFRL858R-T790M-C797S cell line refers to a type of cancer cell line that carries specific mutations in the Epidermal Growth Factor Receptor (EGFR) gene.

• EGFR: This gene encodes a protein that plays a crucial role in cell growth and survival. Mutations in EGFR can lead to uncontrolled cell growth and the development of cancer.

• L858R, T790M, C797S: These are specific mutations within the EGFR gene:

  • L858R: An activating mutation that causes the EGFR protein to become constitutively active, promoting uncontrolled cell growth.

  • T790M: A resistance mutation that arises in response to treatment with first-generation EGFR tyrosine kinase inhibitors (TKIs).

  • C797S: A further resistance mutation that emerges in response to third-generation EGFR TKIs, which were developed to overcome the T790M resistance.

  
  

Significance of EGFRL858R-T790M-C797S cell lines:

• Understanding Drug Resistance: These cell lines provide valuable models for studying the mechanisms of drug resistance in lung cancer, particularly the emergence of resistance to EGFR TKIs.

• Drug Discovery: They can be used to screen and develop new drugs that can overcome these resistance mechanisms and effectively target cancers with these specific EGFR mutations.

• Preclinical Research: These cell lines can be used in preclinical studies to evaluate the efficacy and safety of new treatment approaches, such as targeted therapies or immunotherapies.

Key Points:

• EGFRL858R-T790M-C797S cell lines represent a significant challenge in the treatment of lung cancer.

• Understanding the mechanisms of resistance driven by these mutations is crucial for developing more effective therapies.

• Continued research using these cell lines is essential for improving the outcomes for patients with EGFR-mutant lung cancer.

Image

生產廠家Supplier:

BioVector NTCC質粒載體菌株細胞蛋白抗體基因保藏中心

E-mail:BioVector@163.com

http://www.biovector.net